Publication Name	World Journal of Gastroenterology
Manuscript ID	30795
Country	South Korea

Received	2016-10-18 10:46
Peer-Review Started	2016-10-18 18:49
First Decision by Editorial Office Director
Return for Revision	2016-11-02 19:07
Revised	2016-11-21 08:12
Publication Fee Transferred
Second Decision by Editor	2017-01-16 11:01
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2017-01-18 16:19
Articles in Press	2017-01-18 16:19
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-02-07 22:02
Publish the Manuscript Online	2017-02-12 17:23

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
Manuscript Source	Unsolicited Manuscript
All Author List	Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Hae Koo Kim and Young Dal Lee
Funding Agency and Grant Number
Corresponding Author	Moo In Park, MD, Professor, Department of Internal Medicine, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 49267, South Korea. mipark@kosinmed.or.kr
Key Words	Helicobacter pylori; Disease eradication; Treatment failure; Bismuth; Diabetes mellitus
Core Tip	This study investigated the efficacy of 7 d of second-line bismuth-containing quadruple therapy for Helicobacter pylori (H. pylori) infection and identified risk factors for eradication failure in South Korea. The overall eradication rate per-protocol analysis was 94.5% in the current study. Additionally, diabetes mellitus was related to H. pylori eradication therapy failure. Therefore, second-line bismuth-containing quadruple therapy for H. pylori infection is still worth considering in South Korea, and diabetes mellitus is suggested to be a risk factor for eradication failure.
Publish Date	2017-02-12 17:23
Citation	Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066
URL	http://www.wjgnet.com/1007-9327/full/v23/i6/1059.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i6.1059

Full Article (PDF)	WJG-23-1059.pdf
Full Article (Word)	WJG-23-1059.doc
Manuscript File	30795-Review.docx
Answering Reviewers	30795-Answering reviewers.pdf
Audio Core Tip	30795-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	30795-Conflict-of-interest statement.pdf
Copyright License Agreement	30795-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20161017163903.pdf
Institutional Review Board Approval Form or Document	30795-Institutional review board statement.PDF
Non-Native Speakers of English Editing Certificate	30795-Language certificate.pdf
Peer-review Report	30795-Peer-review(s).pdf
Scientific Misconduct Check	30795-Scientific misconduct check.pdf
Scientific Editor Work List	30795-Scientific editor work list.pdf